Samil Pharmaceutical Co.,Ltd
Research Samil Pharmaceutical Co.,Ltd (000520.KS) on Bullrun: market cap KRW 174.81B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker000520.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 174.81B
- Financial periodQ2 2026
- RevenueKRW 50.60B
- Net income-KRW 7.69B
- Free cash flow-KRW 4.07B
- Gross margin37.4%
Valuation Snapshot
latest market cap is KRW 174.81B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 174.81B | n/a | n/a | n/a |
About Samil Pharmaceutical Co.,Ltd
Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Samil Pharmaceutical Co.,Ltd's market cap?
Samil Pharmaceutical Co.,Ltd's market capitalization is KRW 174.81B.
What does Samil Pharmaceutical Co.,Ltd do?
Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments.